RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (NASDAQ:CBTE), a solutions provider to the global biotechnology industry, government agencies, pharmaceutical companies, and academic institutions, today released its financial results for the third quarter ended September 30, 2006 (the “2006 Quarter”). The Company’s 10-QSB is expected to be released on or about November 14, 2006. The third quarter and year-to-date losses now being reported are attributable to the lack of contract signings earlier in the year and to delayed and canceled contracts experienced throughout the course of the year.
